Hennion & Walsh Asset Management, Inc. Orchard Therapeutics PLC Transaction History

Hennion & Walsh Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.42 - $0.78 $68,954 - $128,058	-164,178 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$0.7 - $1.51 $5,782 - $12,472	-8,260 Reduced 4.79%	164,178 $117,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $12,653 - $24,324	-10,908 Reduced 5.95%	172,438 $228,000
Q3 2021 Nov 12, 2021	SELL	$2.24 - $4.29 $20,328 - $38,931	-9,075 Reduced 4.72%	183,346 $422,000
Q2 2021 Aug 13, 2021	BUY	$4.39 - $7.23 $31,612 - $52,063	7,201 Added 3.89%	192,421 $845,000
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $813,115 - $1.68 Million	185,220 New	185,220 $1.35 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.